Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05683379
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD
Sponsor: REGENXBIO Inc.
View on ClinicalTrials.gov
Summary
This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).
Official title: Anti-AAV8 Antibody Assessment Study of Males With Duchenne Muscular Dystrophy Aged 0 to <25 Years
Key Details
Gender
MALE
Age Range
0 Years - 25 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2022-12-20
Completion Date
2026-09
Last Updated
2025-11-25
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
AAV8 DetectCDx
An in vitro diagnostic assay to detect antibodies to AAV8 in human serum specimens.
Locations (1)
Rare Disease Research
Atlanta, Georgia, United States